Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Objective Biotechnology
Minneapolis, Minnesota, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Objective Biotechnology has launched the Autoinjector, a fully automated, vision-guided robotic system for microinjection in genetic research—commercially available and validated for high-throughput genetic manipulation in model organisms. The Autoinjector has been successfully deployed for gene editing and transgenesis in both insects and vertebrates, enabling faster and more reproducible creation of transgenic models[5][7].
- Modalities
- DeviceAutomated Microinjection SystemOptical Recording Device
- Industry
- Non-Drug Biotech
02
Partnerships
University of Minnesota
Beyond the preview
Go deeper on Objective Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Objective Biotechnology.